Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HIF1A | Q16665 | 8/20 | 0.44 |
| ▸ | S1PR1 | P21453 | 6/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3752470 | 0.93 | HIF1A (0.43) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL3753794 | 0.90 | HIF1A (0.44) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL3763382 | 0.90 | HIF1A (0.46) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL3757516 | 0.90 | HIF1A (0.55) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL3752559 | 0.90 | HIF1A (0.51) | HIF1AS1PR1NPC1RAB9AKMT2A | |
| SCHEMBL3755357 | 0.89 | HIF1A (0.43) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL23971823 | 0.87 | HIF1A (0.53) | HIF1AS1PR1NPC1RAB9AHPGD | |
| SCHEMBL23972133 | 0.86 | HIF1A (0.48) | HIF1AS1PR1RAB9AHPGDLMNA | |
| SCHEMBL23972134 | 0.85 | HIF1A (0.48) | HIF1AS1PR1NPC1RAB9AKMT2A | |
| SCHEMBL23972067 | 0.85 | HIF1A (0.48) | HIF1AS1PR1HPGDLMNAMAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | claimed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | claimed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | claimed |
| EP-2231591-B1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORP (KR) | 2015-02-11 | — | — | EP | disclosed |
| US-8410302-B2 | Methoxyimino compounds and fungicide composition comprising same | KYUNG NONG CORPORATION (KR) | 2013-04-02 | — | — | US | disclosed |
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | KYUNG NONG CORPORATION (KR) | 2010-11-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100298593-A1 | METHOXYIMINO COMPOUNDS AND FUNGICIDE COMPOSITION COMPRISING SAME | CYP51A1, MSMO1, MTMR1 | HIF1A 3994/4885S1PR1 3069/4885NPC1 2127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.